The relation between survival and age at diagnosis in breast cancer
- PMID: 3736639
- DOI: 10.1056/NEJM198608283150906
The relation between survival and age at diagnosis in breast cancer
Abstract
We analyzed the relation between age at diagnosis and relative survival (ratio of observed to expected survival) in 57,068 women in Sweden in whom breast cancer was diagnosed in 1960 to 1978 (about 98 percent of all cases). Women who were 45 to 49 years old had the best prognosis, with a relative survival exceeding that of the youngest patients (less than 30 years) by 7.6 to 12.9 percent at different periods of observation. Relative survival declined markedly after the age of 49--particularly in women aged 50 to 59--and the oldest women (greater than 75) had the worst rate. The difference in relative survival between those older than 75 and those 45 to 49 increased from 8.6 percent at 2 years to 12.2, 20.3, and 27.5 percent after 5, 10, and 15 years of follow-up, respectively. The long-term annual mortality rate due to breast cancer approached 1 to 2 percent at the premenopausal ages but exceeded 5 percent throughout the period of observation in the oldest age group. An understanding of the biologic basis for the complex relation between age and prognosis might provide a better understanding of the natural history of breast cancer in women.
Similar articles
-
Long-term survival in 406 males with breast cancer.Br J Cancer. 1985 Jul;52(1):99-103. doi: 10.1038/bjc.1985.155. Br J Cancer. 1985. PMID: 4015955 Free PMC article.
-
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.Am J Epidemiol. 1989 Aug;130(2):221-8. doi: 10.1093/oxfordjournals.aje.a115328. Am J Epidemiol. 1989. PMID: 2750723
-
Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway.Int J Cancer. 2013 Jan 1;132(1):174-81. doi: 10.1002/ijc.27593. Epub 2012 May 14. Int J Cancer. 2013. PMID: 22511284
-
Survival of breast cancer patients from Piedmont, Italy.Cancer Causes Control. 1993 May;4(3):209-15. doi: 10.1007/BF00051315. Cancer Causes Control. 1993. PMID: 8318637 Review.
-
Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet. 2002 Mar 16;359(9310):909-19. doi: 10.1016/S0140-6736(02)08020-0. Lancet. 2002. PMID: 11918907 Review.
Cited by
-
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.J Clin Transl Hepatol. 2020 Sep 28;8(3):285-291. doi: 10.14218/JCTH.2020.00021. Epub 2020 Aug 10. J Clin Transl Hepatol. 2020. PMID: 33083251 Free PMC article.
-
Optimal management of breast cancer in the elderly patient: current perspectives.Clin Interv Aging. 2015 Jan 6;10:157-74. doi: 10.2147/CIA.S50670. eCollection 2015. Clin Interv Aging. 2015. PMID: 25609933 Free PMC article. Review.
-
The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.Ann Surg Oncol. 2022 Jun;29(6):3810-3819. doi: 10.1245/s10434-022-11367-w. Epub 2022 Mar 5. Ann Surg Oncol. 2022. PMID: 35246810 Free PMC article.
-
Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors.Eur J Breast Health. 2019 Oct 1;15(4):262-267. doi: 10.5152/ejbh.2019.4860. eCollection 2019 Oct. Eur J Breast Health. 2019. PMID: 31620686 Free PMC article.
-
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.Cancer Med. 2023 Sep;12(18):18850-18860. doi: 10.1002/cam4.6509. Epub 2023 Sep 8. Cancer Med. 2023. PMID: 37688399 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical